Polio - The Virus and It’s Effect

“Polio spreads from person to person invading the brain and spinal cord and causing paralysis (inability to move). " – CDC, 2014

“Most people who get infected with poliovirus (about 72 out of 100) will not have any visible symptoms.” – CDC, 2014

Polio Table of Contents (page navigation)

 Annual U.S. Mortality Rate for Polio

Less than 1 death per year – CDC, 2014

“Most people with polio have no symptoms; minor symptoms such as limb pain, fatigue and nausea affect about 4% to 8% of patients, according to the CDC. Fewer than 1% of cases lead to patients becoming permanently paralyzed, usually in the legs.” – CNN, 2012

“Paralysis is the most severe symptom associated with polio because it can lead to permanent disability and death. Between 2 and 10 out of 100 people who have paralysis from poliovirus infection die because the virus affects the muscles that help them breathe.” – CDC, 2014

Polio Decline Not from Vaccine's Efficacy

"The fact that dubious tactics were used to fabricate efficacy rates was corroborated by Dr. Bernard Greenberg, chairman of the Committee on Evaluation and Standards of the American Public Health Association during the 1950s. His expert testimony was used as evidence during Congressional hearings in 1962. He credited the “decline” of polio cases not to the vaccine, but rather to a change in the way doctors were required to report cases: “Prior to 1954 any physician who reported paralytic poliomyelitis was doing his patient a service by way of subsidizing the cost of hospitalization... two examinations at least 24 hours apart was all that was required... In 1955 the criteria were changed... residual paralysis was determined 10 to 20 days after onset of illness and again 50 to 70 days after onset... This change in definition meant that in 1955 we started reporting a new disease... Furthermore, diagnostic procedures have continued to be refined." - Neil Z Miller - The Polio Vaccine: A Critical Assessment of its Arcane History, Efficacy, and Long-term Health-related Consequences, 2004

Let's take a second to step back in time to the early days of the competing Polio vaccines on the market, the 'live-virus' (Sabin) and the 'killed-virus' (Salk) polio vaccines. If you have some time, read this article in it's entirety from the Chicago Tribune, March 5, 1961. It reveals changes in diagnosis, which broadened the range of the defined term 'epidemic' from 20 cases out of 100,000 to 35 cases out of 100,000. These alterations dramtically impact the statistics boosting the seeming 'effectivenss' of the vaccine.

But the paper goes on further, quoting Dr. Herald Cox, director of virus research at Lederle Laboratories and president elect of the Society of American Bacterologists, "We are now learning, not only in the United States, but in Israel, England, and Denmark, that the killed product does a fairly good job of producing anitbodies against type II poliovirus," said Dr. Cox. "But Type II represents only about 3 per cent of paralytic cases throughout the world. The killed vaccine does a poor job against Type I, however, which causes 85 per cent of paralytic cases, and against Type III, which causes about 12 per cent. "In other words, the killed vaccine is doing its best job against the least important type. It took time to find this out. It was proven in Israel in 1958, when it had its big Type I epidemic. They did not see any difference in protection between the vaccinated and the unvaccinated. Last year in Massachusetts during a Type III outbreak, there were more paralytic cases in the triple vaccinates than in the unvacinated."

Admissions - Polio Vaccine Causing Cancer

As the developer of Merck's vaccine program, Dr. Maurice Hilleman developed more than three dozen vaccines, which is more than any other scientist in history. In this archived interview excerpt recorded by WGBH, Boston’s Public Broadcasting Station, you will hear his own admission that, "vaccines have to be considered the bargain basement technology for the 20th Century." This is quite a statement from someone who should be the proudest and utmost progenitor of vaccines’ safety and effectiveness.

When he spoke about bringing the monkeys over from Africa, which they used to manufacture the polio vaccine, he had this to say, “I brought African greens in. I didn’t know we were importing AIDS virus at the time.” And following the two reporters’ outburst of laughter, Dr. Hilleman replied, “This is the real story.” A little later in the interview, Dr. Hilleman stated, “Yellow fever vaccine had leukemia virus in it. This was in the day of very crude science.” He continues, by telling of his conversation with Dr. Albert Sabin, the creator of the oral Polio vaccine, over the effect it was having on their test population, the Russians. He said, “I have a feeling in my bones that this virus is different. I don’t know why I am telling you this, but I’ve been around biology a long time. But I just think this virus may have some long term effects. And he just said what? And I said, “Cancer.


A cancer-causing monkey virus grown in their kidneys – SV-40 - was administered to millions between 1955-1961. In fact, “our analysis indicates increased rates of ependymomas (37%), osteogenic sarcomas (26%), other bone tumors (34%) and mesothelioma (90%) among those in the exposed as compared to the unexposed birth cohort.” - AntiCancer Research, 1999

Presence of simian virus 40 (SV-40) DNA sequence in human lymphomas might be a pathogenesis of non-Hodgkins lymphomas. "SV40 is significantly associated with some types of non-Hodgkin lymphoma. These results add lymphomas to the types of human cancers associated with SV40." – The Lancet, 2002

"These results establish that SV40 is associated significantly with brain tumors, bone cancers, malignant mesothelioma, and non-Hodgkin's lymphoma." - American Journal of Medicine, 2003

"We conclude that SV40 is significantly associated with some types of NHL (non-Hodgkins Lymphomas) and that lymphomas should be added to the types of human cancers associated with SV40." - Leuk Lymphoma, 2003

Vaccine Linked to Increased Likelihood of Polio

"In 1995, the New England Journal of Medicine published a study showing that children who received a single injection within one month after receiving a polio vaccine were 8 times more likely to contract polio than children who received no injections." – Neil Z Miller - The Polio Vaccine: A Critical Assessment of its Arcane History, Efficacy, and Long-term Health-related Consequences, 2004

 “The live attenuated strains used in the oral poliovirus (OPV) … strains replicate in the human gut and are excreted for several weeks after immunization…This may, in rare cases, cause vaccine-associated paralytic poliomyelitis (VAPP) in vaccinees or result in transmissible and neurovirulent circulating vaccine-derived poliovirus (cVDPV) strains.” - Vaccine, 2009

So, let's take a look at the data. Did the cases of polio decrease after the vaccine? Well, in fact, no. The chart to the left shows 5 states (MA, CT, NH, RI, VT) that were sampled show an increase in polio after the vaccine ranging from (266% - 642%). – Neil Z Miller - The Polio Vaccine: A Critical Assessment of its Arcane History, Efficacy, and Long-term Health-related Consequences, 2004 via US Government Statistics

The Vaccine Creates New Cases of Polio

In fact, according to CDC figures, every case of polio in U.S. since 1979 was caused by the polio vaccine or from foreigners bringing wild polio into the U.S.CDC - Morbidity and Mortality Report, 1999

The wild polio virus brought about the development of polio vaccines, which spawned mutations of the polio virus, resulting in new “vaccine-derived” polio viruses. – The Lancet, 2001; CDC –Poliomyelitis Prevention in the United States, 1990

On September 24, 1976, The Washington Post, 2006 reported Dr. Jonas Salk’s assertion that the live oral virus vaccine of Dr. Albert Sabin had been the cause of reported polio cases in the US since 1961.

"Vaccine-derived polioviruses (VDPVs), strains of poliovirus mutated from the oral polio vaccine, pose a challenge to global polio eradication. Immunodeficiency-related vaccine-derived polioviruses (iVDPVs) are a type of VDPV which may serve as sources of poliovirus reintroduction after the eradication of wild-type poliovirus." - Vaccine, 2015

"The oral vaccines are inexpensive, costing about 12 cents per dose, and simple to administer. But they are not foolproof. In one out of every few million recipients, they cause polio paralysis. Immune-impaired individuals can become long-term shedders of the virus." - Center for Infectious Disease Research and Policy, 2008

The Polio Vaccine Can Shed

"Maximum viral shedding occurs in the first 1–2 weeks after vaccination, particularly after the first dose. Vaccine viruses may spread from the recipient to contacts. Persons coming in contact with fecal material of a vaccinated person may be exposed and infected with vaccine virus...Infected persons without symptoms shed virus in the stool and are able to transmit the virus to others." - CDC, 2010

"Fecal shedding of virulent revertant polioviruses was examined in isolates from infants previously immunized with > or = 1 dose of orally administered live attenuated polio vaccine (OPV) alone, enhanced-potency inactivated polio vaccine (EIPV) alone, or a combination of both." - The Journal of Infectious Diseases, 1993

Vaccine Shedding (def.) - the transmission of the virus from a vaccinated person to an unvaccinated person.

"A Staten Island man stricken with polio after changing his daughter's diaper 30 years ago won a multimillion dollar judgment from the maker of the oral vaccine that passed through her stool." He "was awarded $22.5 million. The jury determined that the Orimune vaccine his daughter, Diana, received was "unreasonably dangerous" and that drugmaker Lederle Laboratories was "100% liable" for his injuries." - NY Daily News, 2009